Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 5 to 9, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 5 to 9, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
In-Hospital SARS-CoV-2 Mortality Declined Throughout Pandemic
FRIDAY, April 9, 2021 (HealthDay News) — In-hospital mortality for severe acute respiratory syndrome coronavirus 2-positive patients of all ages has declined throughout the pandemic period, according to a study published online April 8 in JAMA Network Open.
Supply of J&J COVID-19 Vaccine to Drop 86 Percent Next Week
FRIDAY, April 9, 2021 (HealthDay News) — In a setback to a national vaccination campaign that was finally gaining ground, the federal government said Thursday that Johnson & Johnson will allocate 86 percent fewer doses of its COVID-19 vaccine across the United States next week.
First Living Donor Transplant of Lung Tissue to COVID-19 Patient Announced
FRIDAY, April 9, 2021 (HealthDay News) — The world’s first transplant of lung tissue from living donors to a COVID-19 patient with severe lung damage was announced Thursday by doctors in Japan.
CDC: Risk for Catching Coronavirus From Surfaces Is Low
FRIDAY, April 9, 2021 (HealthDay News) — The risk for catching the new coronavirus from surfaces is low, the U.S. Centers for Disease Control and Prevention said this week in what some experts say is a long overdue announcement.
Antibodies Persist Six Months After Second Dose of Moderna COVID-19 Vaccine
FRIDAY, April 9, 2021 (HealthDay News) — Antibodies persist through six months after the second dose of the Moderna COVID-19 mRNA vaccine, according to a letter to the editor published online April 6 in the New England Journal of Medicine.
Blood Type Not Associated With COVID-19 Outcomes
FRIDAY, April 9, 2021 (HealthDay News) — Blood type is not associated with COVID-19 susceptibility or outcomes, according to a research letter published online April 5 in JAMA Network Open.
Mortality Risk Up for Dialysis Patients in March to July 2020
FRIDAY, April 9, 2021 (HealthDay News) — Patients undergoing dialysis and those with kidney transplants had increased mortality risk in 2020 compared with 2017 to 2019, according to a study published online April 8 in the Journal of the American Society of Nephrology.
NIH Starts Trial Looking at Rare Allergic Reactions to COVID-19 Vaccines
THURSDAY, April 8, 2021 (HealthDay News) — A new clinical trial will investigate whether people who are highly allergic or have a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines.
Poll: Despite Pandemic’s Toll, Many Older Adults Do Not Have Living Wills
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
